Um programa baseado na Web para ajudar cuidadores de pacientes pulmonares a aprender sobre os recursos disponíveis de cuidados de suporte (CONNECT)
Planejamento oncológico comunitário em vários locais para a intervenção CONNECT voltada para cuidadores de câncer de pulmão
Clinical trial that tests the feasibility of a web based caregiver support resource, along with caregiver navigation sessions for caregivers of patients with stage II-IV lung cancer. The Caregiver Oncology Needs Evaluation Tool (CONNECT) is a novel web-based intervention designed for the community oncology setting, to systematically connect lung cancer caregivers with tailored supportive care resources. Lung cancer caregivers provide critical and challenging care for their loved ones and are at risk for their own negative psychosocial and physical outcomes. Implementing the CONNECT program along with caregiver navigation may provide additional support to caregivers of patients with stage II-IV lung cancer.
Visão geral do estudo
Status
Descrição detalhada
This study is a multi-site randomized pilot trial enrolling 120 lung cancer caregiver-patient dyads (i.e., lung cancer caregivers (n=120) and their care-recipients (n=120)) across approximately 8-12 practices to assess the multi-site feasibility of a caregiver technology-based intervention (CONNECT) to identify caregivers' needs and connect them with supportive care resources. Caregivers will be randomized 1:1:1 to either the CONNECT intervention, usual care comparison group or generic resource list comparison group. CONNECT is a web-based intervention that empowers and educates caregivers about the benefits of supportive care services and systematically identifies unmet needs to connect lung cancer caregivers with tailored supportive care resources. The Central Caregiver Navigator will assist caregivers with resolving barriers to accessing resources and work with the Local Practice Referral Coordinator to process referrals. Caregivers and patients will complete measures at baseline (prior to caregiver randomization), and 12 and 24 weeks after baseline. Feasibility measures (retention, accrual rates, and participation) will be evaluated to inform the future trial. The Local Practice Referral Coordinator for each practice will report on time needed for practice participation, referral processes, and communication processes with the Central Caregiver Navigator.
Participants (i.e., patients or care-recipients) will be asked to complete study surveys at three time points:
- After consenting and before randomization of participant and caregiver. (Initial survey)
- Approximately 12 weeks after completing the first survey (12-week survey)
- Approximately 24 weeks after completing the first survey (24-week survey)
Each survey will take about 30-45 minutes to complete. The forms will ask about things such as demographics (sex, race, etc.), cancer symptoms, satisfaction with cancer care and health behaviors. You don't have to answer any question that makes you feel uncomfortable. These surveys can be done remotely over the internet, in the clinic, by phone or by mail.
Caregivers will also complete surveys at three time points and will be assigned to 1 of 3 study groups:
- Group 1 will be given the usual care provided at your clinic. At the completion of the study, this group will be given the generic supportive care resource list for their use that Group 2 received.
- Group 2 will be provided with a generic supportive care resource list.
- Group 3 will be asked to watch a brief video and complete the web-based CONNECT program either in the clinic or on your own device. The CONNECT program is designed to help identify any unmet needs and connect the caregiver with tailored supportive care resources, based on specific needs. The CONNECT Navigator will follow-up with within 2 business days of completion of the program and again 4 weeks later.
Caregiver Participants (Group 1, 2 and 3) will be asked to complete study surveys at three time points:
- After consenting and before randomization of participant and caregiver. (Initial survey)
- Approximately 12 weeks after completing the first survey (12-week survey)
- Approximately 24 weeks after completing the first survey (24-week survey)
Each survey will take about 35-45 minutes to complete. The forms will ask about things such as demographics (sex, race, etc.), caregiving experience, use of supportive care resources, quality of life, mood, and social needs (housing, transportation, utilities, etc). You don't have to answer any question that makes you feel uncomfortable.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Colorado
-
Denver, Colorado, Estados Unidos, 80205
- Kaiser Permanente-Franklin
-
Lafayette, Colorado, Estados Unidos, 80026
- Kaiser Permanente - Rock Creek
-
Lone Tree, Colorado, Estados Unidos, 80124
- Kaiser Permanente - Lone Tree
-
-
Delaware
-
Millville, Delaware, Estados Unidos, 19967
- Beebe South Coastal Health Campus
-
Rehoboth Beach, Delaware, Estados Unidos, 19971
- Beebe Health Campus
-
-
Georgia
-
Augusta, Georgia, Estados Unidos, 30912
- Augusta University Medical Center
-
-
Hawaii
-
Honolulu, Hawaii, Estados Unidos, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
‘Aiea, Hawaii, Estados Unidos, 96701
- Hawaii Cancer Care - Westridge
-
-
Missouri
-
Osage Beach, Missouri, Estados Unidos, 65065
- Lake Regional Hospital
-
Springfield, Missouri, Estados Unidos, 65807
- CoxHealth South Hospital
-
-
New York
-
The Bronx, New York, Estados Unidos, 10461
- Montefiore Medical Center-Einstein Campus
-
-
North Carolina
-
Winston-Salem, North Carolina, Estados Unidos, 27157
- Wake Forest NCORP Research Base
-
-
Pennsylvania
-
Scranton, Pennsylvania, Estados Unidos, 18510
- Community Medical Center
-
Wilkes-Barre, Pennsylvania, Estados Unidos, 18711
- Geisinger Wyoming Valley/Henry Cancer Center
-
-
South Carolina
-
Gaffney, South Carolina, Estados Unidos, 29341
- Gibbs Cancer Center-Gaffney
-
Greenville, South Carolina, Estados Unidos, 29615
- Prisma Health Cancer Institute - Eastside
-
Greenville, South Carolina, Estados Unidos, 29605
- Prisma Health Cancer Institute - Butternut
-
Greer, South Carolina, Estados Unidos, 29651
- Gibbs Cancer Center-Pelham
-
Spartanburg, South Carolina, Estados Unidos, 29303
- Spartanburg Medical Center
-
Union, South Carolina, Estados Unidos, 29379
- MGC Hematology Oncology-Union
-
-
Wisconsin
-
Appleton, Wisconsin, Estados Unidos, 54911
- ThedaCare Regional Cancer Center
-
Green Bay, Wisconsin, Estados Unidos, 54311
- Aurora BayCare Medical Center
-
Kenosha, Wisconsin, Estados Unidos, 53142
- Aurora Cancer Care-Kenosha South
-
Milwaukee, Wisconsin, Estados Unidos, 53215
- Aurora Saint Luke's Medical Center
-
Neenah, Wisconsin, Estados Unidos, 54956
- ThedaCare Regional Medical Center - Neenah
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Patient Inclusion Criteria:
- Must be ≥ 18 years of age, as this study is focused on the experience of adult patient-caregiver dyads
- Must have a current diagnosis of new (i.e., initial diagnosis) or recurrent stage II-IV lung cancer
- Must be enrolled after the start of anticancer systemic therapy (+/- radiation therapy) with at least 9 weeks of any planned anticancer treatment remaining
- Must be ambulatory and up (i.e., not bedridden) more than 50% of waking hours
- Must self-report receiving informal (i.e., not professional) care from a caregiver who meets the study caregiver criteria and who is willing to participate
Caregiver Inclusion Criteria:
- Must be ≥18 years of age, as this study is focused on the experience of adult patient-caregiver dyads
- Must self-report providing informal (i.e. not professional) care during cancer treatment for a patient who meets the patient criteria and who is willing to participate
- Must have access to the internet at home or be willing to use CONNECT in the clinic
- Must have access to telephone to complete sessions with the central caregiver navigator
Patient Exclusion Criteria:
- Patients who have completed treatment for their lung cancer at the time of study enrollment
- Enrolled in hospice care
- Unable to read and English and not willing to have someone read surveys for them
Caregiver Exclusion Criteria:
- Self-report currently receiving cancer treatment
- Unable to read and communicate in English, as the CONNECT intervention is currently only available in English
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Group 1 (Standard care followed by generic resource list)
Caregivers receive standard care and are then given a generic resource list at week 24. |
Receive a generic resource list |
|
Comparador Ativo: Group 2 (Generic resource list)
Caregiver receive a generic resource list at the start of the study. |
Receive a generic resource list |
|
Experimental: Group 3 (CONNECT, personalized list, and navigation)
Caregivers receive access to the CONNECT tool, watch an educational video on self care and receive a personalized list of resources based on caregiver preferences. Caregivers also receive access to and complete at least 2 calls, at baseline and at week 4, with a caregiver navigator to review the resource list and address any additional needs. |
Receive personalized resource list Receive access to CONNECT tool Complete calls with caregiver navigator
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Caregiver retention at 12 weeks
Prazo: At 12 weeks
|
Calculated as the following: Number of caregivers who complete at least 75% of the 12-week assessments divided by the number randomized. Retention will be estimated and reported along with an exact 95% confidence interval. |
At 12 weeks
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Caregiver accrual rate
Prazo: Upon completion of recruitment, approximately 12 months
|
Number of caregivers who agree to participate divided by the number of months of recruitment |
Upon completion of recruitment, approximately 12 months
|
|
Caregiver participation
Prazo: Upon completion of recruitment, approximately 12 months
|
Proportion of eligible caregivers who agreed to participate |
Upon completion of recruitment, approximately 12 months
|
|
Caregiver retention at 24 weeks
Prazo: At 24 weeks
|
Number of caregivers who complete at least 75% of the 24-week assessments divided by the number randomized. |
At 24 weeks
|
|
Caregiver acceptability
Prazo: At 12 weeks
|
Self-report survey developed for this study to assess the degree to which caregivers found different aspects of CONNECT, the generic resource list, or usual care helpful using a Likert response from 0 (Not at all) to 5 (Very Much) |
At 12 weeks
|
|
Average time (minutes) needed for training for Local Practice Referral Coordinator
Prazo: At completion of training, up to 6 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
At completion of training, up to 6 months
|
|
Desired modality for training (e.g., live webinar, recorded video, paper materials) for Local Practice Referral Coordinator
Prazo: At completion of training, up to 6 months
|
Will be summarized using appropriate descriptive statistics. |
At completion of training, up to 6 months
|
|
Average time (minutes) needed to identify and enter local resources into the Caregiver Oncology Needs Evaluation Tool (CONNECT) database
Prazo: At conclusion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
At conclusion of practice intervention activities, an average of 18 months
|
|
Frequency of needed resource updates in the CONNECT database
Prazo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range |
Up to completion of practice intervention activities, an average of 18 months
|
|
Average time (minutes) spent by the Central Caregiver Navigator and Local Practice Referral Coordinators with each caregiver in the CONNECT arm
Prazo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Modality of contact (e.g. phone, virtual web meeting, email) made by the Central Caregiver Navigator and Local Practice Referral Coordinators with each caregiver in the CONNECT arm
Prazo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized using appropriate descriptive statistics. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Number of contacts made by the Central Caregiver Navigator and Local Practice Referral Coordinators with each caregiver in the CONNECT arm
Prazo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Number of referrals facilitated by the Local Practice Referral Coordinator and Central Caregiver Navigator
Prazo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Type of referrals (e.g., in person, online) facilitated by the Local Practice Referral Coordinator and Central Caregiver Navigator
Prazo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized using appropriate descriptive statistics. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Average time (minutes) needed to communicate for Central Caregiver Navigator and Local Practice Referral Coordinator
Prazo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized across practices using mean, median, standard deviation and interquartile range. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Modalities used for communication (e.g., phone, virtual web meeting, email) for Central Caregiver Navigator and Local Practice Referral Coordinator
Prazo: Up to completion of practice intervention activities, an average of 18 months
|
Will be summarized using appropriate descriptive statistics. |
Up to completion of practice intervention activities, an average of 18 months
|
|
Improvements for the future trial from Local Practice Referral Coordinator's perspectives from a survey at the end of the study
Prazo: At completion of practice intervention activities, an average of 18 months
|
Will be summarized using appropriate descriptive statistics. |
At completion of practice intervention activities, an average of 18 months
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Patient accrual rate
Prazo: Upon completion of recruitment, approximately 12 months
|
Number of patients who agree to participate divided by the number of months of recruitment |
Upon completion of recruitment, approximately 12 months
|
|
Patient participation rate
Prazo: Upon completion of recruitment, approximately 12 months
|
Proportion of eligible patients who agreed to participate |
Upon completion of recruitment, approximately 12 months
|
|
Patient retention at 12 weeks
Prazo: At 12 weeks
|
Number of patients who complete at least 75% of the 12-week assessments divided by the number randomized |
At 12 weeks
|
|
Patient retention at 24 weeks
Prazo: At 24 weeks
|
Number of patients who complete at least 75% of the 24-week assessments divided by the number randomized |
At 24 weeks
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Cadeira de estudo: Kathryn Weaver, PhD, Wake Forest University Health Sciences
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
- Neoplasias por local
- Neoplasias
- Doenças Respiratórias
- Doenças pulmonares
- Neoplasias do Trato Respiratório
- Neoplasias Torácicas
- Neoplasias Pulmonares
- Administração de Serviços de Saúde
- Terapêutica
- Atendimento ao paciente
- Serviços de Saúde
- Instalações de saúde Força e serviços de trabalho
- Gerenciamento de atendimento ao paciente
- Cuidados de saúde abrangentes
- Cuidado centrado no paciente
- Atenção de saúde primária
- Cuidado paliativo
- Navegação do paciente
Outros números de identificação do estudo
- IRB00112187
- NCI-2023-10870 (Outro identificador: NCI Trial Identifier)
- Lead Organization Identifier (Outro identificador: WF-2301CD)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Wake Forest NCORP Research Base is committed to following the NIH Statement on Sharing Research Data (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-032.html). As of July 2018, the WF NCORP RB signed an agreement with NCI to contribute de-identified data and data dictionaries from clinical trials conducted through our RB to the NCI NCTN/NCORP data archive within 6 months of primary and non-primary publications of phase II/III and phase III trials to https://nctn-data-archive.nci.nih.gov/. This will become the primary means for sharing raw data, and we will adhere to the guidelines spelled out in the NCTN/NCORP Data Archive Usage Guide. De-identified data from studies not covered by the agreement (e.g., phase II and observational studies) will be made available upon request. All data files will be de-identified. De-identification procedures will meet the HIPAA criteria as detailed in the Code of Federal Regulations, Part 45, Section 164.514.
Prazo de Compartilhamento de IPD
6 months after publication for a 2 year duration
Critérios de acesso de compartilhamento IPD
upon request to NCORP@wakehealth.edu
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .